Le Lézard
Classified in: Health, Science and technology
Subjects: AWD, NPT, PDT, HSP, ASI, BLK, TRI, NTA, DEI

The Children's Heart Foundation Launches Inaugural Underrepresented Minority in Medicine Research Training Award


NORTHBROOK, Ill. , April 3, 2024 /PRNewswire/ -- The Children's Heart Foundation is proud to introduce the inaugural Underrepresented Minority in Medicine Research Training Award (URMRTA), an initiative aimed at supporting the career development of underrepresented minority individuals in pediatric cardiology research on congenital heart defects (CHDs).

The URMRTA reflects The Children's Heart Foundation's commitment to diversity, equity, and inclusion in healthcare and medical research, specifically pediatric cardiology research related to CHDs. By addressing the disparities and challenges faced by underrepresented minority individuals, we aim to cultivate a more diverse and representative healthcare workforce that provides equitable and accessible care to all communities.

"We're excited to launch this training award as part of our ongoing efforts to promote diversity and excellence in medicine in the area of congenital heart defect research," said Gail Roddie-Hamlin, President & CEO at The Children's Heart Foundation. "Through this grant, we aim to provide support to underrepresented minority individuals pursuing careers in medical research, empowering them to make significant contributions to healthcare innovation and patient care."

The URMRTA will provide the awardee financial assistance, enabling them to advance their research endeavors and excel in their chosen field. Eligible applicants must identify as members of an underrepresented minority group in medicine: Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians, and other Pacific Islanders.

Key details of the training award:

The Children's Heart Foundation invites eligible individuals to apply for the Underrepresented Minority in Medicine Research Training Award. All applicants must submit through our online application portal: https://proposalcentral.com/GrantOpportunities.asp?GMID=273

For more information about the URMRTA, including eligibility criteria and application instructions, please visit https://www.childrensheartfoundation.org/for-researchers/urm.html or contact us at [email protected].

SOURCE The Children's Heart Foundation


These press releases may also interest you

at 07:10
Bruker Corporation is pleased to announce the closing of its acquisition of ELITechGroup ("ELITech") for ?870 million in cash, excluding the carved out ELITech clinical chemistry business. ELITech is a differentiated, fast growing and profitable...

at 07:10
Novocure today reported financial results for the quarter ended March 31, 2024. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy,...

at 07:10
Novocure announced today that it has entered into a new five-year up to $400 million committed senior secured credit facility with funds managed by Pharmakon Advisors, LP. The committed capital will be available to Novocure in four tranches of $100...

at 07:10
Bicycle Therapeutics plc , a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported recent business progress and financial results for the...

at 07:10
Geron Corporation , a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies, today reported financial results and business highlights for the first...

at 07:10
Mind Medicine (MindMed) Inc. (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it plans to host a conference call on Wednesday, May 8,...



News published on and distributed by: